Patent · US Expired

Novel peptide hormones with calcitonin-like activity

US4663309A · kind A · utility

11Cited by
12References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 1985
Grant dateMay 5, 1987
Priority date
Expiry dateFeb 27, 2005

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S930/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of the formula: ##STR1## wherein R.sub.1 is a moiety selected from the group consisting of ##STR2## R.sub.2 -R.sub.22 are amino acid moieties wherein R.sub.2 is an optional moiety which when present is selected from the group consisting of Ser and Gly, PA1 R.sub.8 is Leu or Val, PA1 R.sub.10 is Gln, Lys, or Gly, PA1 R.sub.11, R.sub.14, and R.sub.20 are each independently selected from the group consisting of Gln and Lys, PA1 R.sub.12 is Leu or Trp, PA1 R.sub.13 is Gln or Ser, PA1 R.sub.17 is Gln or His, PA1 R.sub.19 is Leu or Cys, PA1 R.sub.21 is Gln or Thr, PA1 R.sub.22 is an optional moiety which when present is selected from the group consisting of Leu and Tyr; PA0 R.sub.24 -R.sub.31 comprise a series of eight amino acids each independently selected from the group consisting of Gly, Ser, Thr, Cys, Tyr, Asn, Gln, Asp, Glu, Lys, Arg, and His, with the proviso that not more than one of said eight amino acids may be selected from the group consisting of Asp, Glu, Lys, Arg, and His, and with the proviso that no four or more of said eight amino acids will spontaneously form helical, .beta.-sheet, or .beta.-turn conformations; with the further proviso that when R.sub.19 is Cy…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.